General
Preferred name
dexloxiglumide
Synonyms
Loxiglumide (r)-form ()
Loxiglumide, (r)- ()
CR-2017 ()
P&D ID
PD008711
CAS
119817-90-2
Tags
available
drug
Drug indication
Pancreatic malfunction
Drug Status
investigational
approved
Max Phase
Phase 3
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
9
Cayman Chemical Bioactives
34759
ChEMBL Drugs
CHEMBL550781
Drug Repurposing Hub
DrugBank
DB04856
DrugCentral
834
DrugCentral Approved Drugs
834
DrugMAP
DM52HUD
Guide to Pharmacology
889
MedChem Express Bioactive Compound Library
HY-128878
External IDs
24
Properties
(calculated by RDKit )
Molecular Weight
460.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
14
Ring Count
1
Aromatic Ring Count
1
cLogP
4.01
TPSA
95.94
Fraction CSP3
0.57
Chiral centers
1.0
Largest ring
6.0
QED
0.41
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
CCKAR
Cholecystokinin Receptor
MOA
CCK receptor antagonist
Pathway
GPCR/G protein
Neuronal Signaling
Source data